3h
News-Medical.Net on MSNFlavonoids help regulate gut hormones and show promise in managing type 2 diabetesFlavonoids show promise in treating type 2 diabetes mellitus by targeting the enteroendocrine system and regulating key gut ...
Adopting early testing best practices with widescale T1D screening programs across Europe could mitigate the ‘invisible burden’ of diabetes.
New research suggests areas with higher concentrations of microplastics also have higher rates of chronic disease.
Mounjaro, a weekly injection, targets GIP and GLP-1 hormones to enhance insulin release and appetite regulation, aiding ...
23h
News-Medical.Net on MSNEarly antibiotic exposure may boost risk of diabetes later in lifeExposure to antibiotics during a key developmental window in infancy can stunt the growth of insulin-producing cells in the ...
Scientists used advanced data analysis and machine learning to identify the viral proteins that may trigger autoimmune disorders such as type 1 diabetes and rheumatoid arthritis.
Eli Lilly is advancing its diabetes and obesity treatment with an oral drug, orforglipron. In an exclusive interaction, CEO ...
MORE than a hundred people turned up to Ornamental Lakes on Sunday in support of One Walk, an annual campaign for Type 1 ...
COVID infection has been linked to a higher risk of autoimmune disorders, including rheumatoid arthritis and type 1 diabetes.
11h
MedPage Today on MSNOlder Adults Favor Medicare Coverage for Obesity MedsCurrently, there are six FDA approved weight loss medications. They include three GLP-1 receptor agonists -- liraglutide ...
Community leaders and Jordan Health hosted a "Wake Up Call" clinic in Rochester on Tuesday night as part of Diabetes Alert ...
Researchers found no significant increase in the prevalence of diabetes among American adults from 2013 to 2023.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results